Literature DB >> 2579349

Catecholamine inhibition of calcium action potentials in rat locus coeruleus neurones.

J T Williams, R A North.   

Abstract

Intracellular recordings were made from neurones in the nucleus locus coeruleus in a slice of tissue cut from the rat pons. Clonidine (100 nM-10 microM), noradrenaline (10 microM-1 mM) and adrenaline (10 microM-1 mM) all reduced the duration of the spontaneously occurring action potential of the neurones. This effect was also observed on the action potential in the presence of tetrodotoxin, which results from calcium entering the cell. These concentrations of clonidine, noradrenaline and adrenaline always hyperpolarized the membrane. This hyperpolarization was prevented by two procedures which block potassium currents--intracellular caesium and extracellular barium. In conditions of potassium current blockade, noradrenaline (100 microM-1 mM) and adrenaline (20 microM-1 mM) shortened the calcium action potential but clonidine was ineffective even at 10 microM. Adrenaline and noradrenaline also suppressed inward calcium and barium currents measured under voltage clamp. This action of noradrenaline and adrenaline was not prevented by yohimbine (10 microM), propranolol (20 microM) or prazosin (1 microM); it was reduced by a concentration of phentolamine about 100 times higher than its Ke for alpha 2-adrenoceptors on locus coeruleus neurones. It is concluded that noradrenaline and adrenaline can directly inhibit calcium action potentials in locus coeruleus neurones when applied in high concentrations, but that this does not involve an alpha 2-adrenoceptor.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2579349     DOI: 10.1016/0306-4522(85)90167-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  Effect of chronic clonidine treatment on transmitter release from sympathetic varicosities of the guinea-pig vas deferens.

Authors:  D Knight; T C Cunnane; N A Lavidis
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

Review 2.  Calcium channels in cellular membranes.

Authors:  P G Kostyuk
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

3.  alpha2-Adrenoceptor-mediated potassium currents in acutely dissociated rat locus coeruleus neurones.

Authors:  J Arima; C Kubo; H Ishibashi; N Akaike
Journal:  J Physiol       Date:  1998-04-01       Impact factor: 5.182

4.  Suppression of calcium current by an endogenous neuropeptide in neurones of Aplysia californica.

Authors:  V Brezina; R Eckert; C Erxleben
Journal:  J Physiol       Date:  1987-07       Impact factor: 5.182

5.  Actions of noradrenaline recorded intracellularly in rat hippocampal CA1 pyramidal neurones, in vitro.

Authors:  D V Madison; R A Nicoll
Journal:  J Physiol       Date:  1986-03       Impact factor: 5.182

6.  Spontaneous spiking and synaptic depression underlie noradrenergic control of feed-forward inhibition.

Authors:  Sidney P Kuo; Laurence O Trussell
Journal:  Neuron       Date:  2011-07-28       Impact factor: 17.173

7.  Inhibition of Ca-spikes in rat preganglionic cervical sympathetic nerves by sympathomimetic amines.

Authors:  P Elliott; S J Marsh; D A Brown
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

8.  Role of potassium channels in the antinociception induced by agonists of alpha2-adrenoceptors.

Authors:  N Galeotti; C Ghelardini; M C Vinci; A Bartolini
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

Review 9.  Adrenoceptors Modulate Cholinergic Synaptic Transmission at the Neuromuscular Junction.

Authors:  Ellya Bukharaeva; Venera Khuzakhmetova; Svetlana Dmitrieva; Andrei Tsentsevitsky
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

10.  Functional neuroanatomy of the noradrenergic locus coeruleus: its roles in the regulation of arousal and autonomic function part II: physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans.

Authors:  E R Samuels; E Szabadi
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.